Author

Suet Yee Mak

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Alice Cheung· 1 shared Andy O.-T. Wong· 1 shared Anna WalentinssoniD· 1 shared Cláudia CorreiaiD· 1 shared Deborah K. LieuiD· 1 shared Erin G. RobertsiD· 1 shared Jonas ChristofferssoniD· 1 shared Karin JennbackeniD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Alice Cheung

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Reversal of contractile defects by mediating calcium homeostasis in human mini-heart models of heart failure with preserved ejection fraction (HFpEF) leads to first-in-human gene therapy clinical trial

Kevin D. Costa, Andy O.-T. Wong, Suet Yee Mak, Erin G. Roberts, Wendy Keung, Cláudia Correia, Anna Walentinsson, Jonas Christoffersson, Alice Cheung, Deborah K. Lieu, Karin Jennbacken, Qing‐Dong Wang, Roger J. Hajjar, Ronald A. Li

This paper develops human mini-heart models of HFpEF, identifies SERCA2a downregulation, and demonstrates gene therapy efficacy, leading to a first-in-human clinical trial.

bioRxiv · Aug 27, 2024 · PreprintBioengineering